Business Wire

DXC Technology Launches Analytics Migration Factory to Accelerate Global Client Workload Migration to Microsoft Azure

Del

Recognizing the rapidly growing need for global enterprise clients to accelerate the migration of data and analytics to the cloud, DXC Technology (NYSE: DXC) today announced the industry’s first Analytics Migration Factory for Microsoft Azure.

DXC today opened its first factory in Bangalore, India. The company plans to establish two more Analytics Migrations Factories in Warsaw, Poland, and Manila, the Philippines, by December 2018.

DXC’s new Analytics Migration Factory provides clients with an efficient, end-to-end experience for development, delivery and ongoing support services designed for analytics workload migration solutions to Azure. The factory team in Bangalore comprises professionals with advanced skills in data science and cloud architecture, design and deployment as well as Azure skills and certifications. DXC has more than 900 Azure professional certifications, 900 analytics clients and 8,000 analytics and AI professionals worldwide.

“We’ve entered a new artificial intelligence (AI)-based innovation cycle in the digital era,” said Edward Ho, executive vice president and general manager, Offerings, at DXC. “Increasingly, global enterprises want to leverage and benefit from digital innovations like AI and machine learning for smooth, rapid and orchestrated migration of data and analytic workloads from any source to the cloud.

“Our partner, Microsoft, has built Microsoft Azure, a productive cloud platform with a wide portfolio of AI productivity tools that enable clients to unlock the value of their data and build smart applications with incredible speed and agility,” Ho continued. “DXC’s dedicated Azure factory and Azure-certified teams help clients achieve faster, more efficient and safer cloud migrations, while rapidly implementing new applications with innovative tools and integrating pre-built analytics and AI services.”

Rohan Kumar, corporate vice president, Azure Data Platform, Microsoft Corporation, said, “DXC’s Analytics Migration Factory approach is a significant advancement for companies seeking to move their analytics workloads quickly and efficiently to Microsoft Azure and open new opportunities to gain value from their data and analytics.” Kumar said that having analytics capability on a modern cloud platform will also “enable the infusion of artificial intelligence and machine learning, providing additional insight to client businesses.”

Accelerating and Driving Azure Cloud Migration Efficiencies

The DXC Analytics Migration Factory model accelerates and drives migration efficiencies with a deep library of cataloged methods, proven design patterns and best practices, backed by a team of trained and certified migration factory experts. DXC’s application of broader standardization on both Azure tools and select third-party components produces significant process improvements during and following migration to Azure.

Multiple factory lines address core areas of assessment, design, development, testing, and migration deployment — all supported by DXC managed services and comprehensive project management. The factory model increases migration quality and improves scheduling and productivity, while streamlining costs, governance and project execution.

The DXC Analytics Migration Factory employs DXC Bionix™, the company’s secure digital-generation services delivery model that provides a comprehensive approach to intelligent automation at scale. The result is maximum performance and value, with accelerated digital transformation.

Key benefits of the DXC Analytics Migration Factory for Microsoft Azure include:

  • Complete migration solution from assessment to optimization, with an extensive set of analytics services and accelerators;
  • Dedicated functional factory lines with specialized teams certified in Azure technologies and experienced in securing data in public clouds;
  • Consistent and repeatable deployment methods that drive seamless integration and efficiency of the migration process to minimize business disruption;
  • Mature “run” processes, tools, DevOps and detailed usage reporting for optimized management to mitigate the risks in security management, service continuity and workload support; and
  • World class execution model that is complementary to DXC Cloud Services for Microsoft Azure in which specialized tools, methods and skills are deployed to transform and move applications to a hybrid IT infrastructure with Azure.

This provides organizations with the elasticity of cloud for their analytic services to enable new and deeper business insights, to try or test new analytic use cases, and to explore new technologies without incurring unnecessary deep capital outlays.

“Creating a new business model to transform an organization is not easily achieved by large enterprises,” said Ali Zaidi, research director, IT Consulting and Systems Integration Services, IDC. “These organizations are looking for ways to take advantage of new platforms using IoT and analytics solutions, without disrupting the business. The ability to migrate the analytics and data workload efficiently to these platforms, with no business disruption, helps organizations to improve analytic insight while managing risk.”

To learn more about the DXC-Microsoft collaboration, go here.

About DXC Technology

DXC Technology (DXC: NYSE) is the world’s leading independent, end-to-end IT services company, serving nearly 6,000 private and public-sector clients from a diverse array of industries across 70 countries. The company’s technology independence, global talent and extensive partner network deliver transformative digital offerings and solutions that help clients harness the power of innovation to thrive on change. DXC Technology is recognized among the best corporate citizens globally. For more information, visit dxc.technology.

Contact information

DXC Technology
Richard Adamonis
Corporate Media Relations
+1-862-228-3481
radamonis@dxc.com
or
Donna Jenks
Corporate Media Relations
+1-630-306-9989
donna.jenks@dxc.com
or
Jonathan Ford
Investor Relations
+1-703-245-9700
jonathan.ford@dxc.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Grand Prize Winner in $1.75M Water Abundance XPRIZE Announced at XPRIZE Visioneering 201822.10.2018 17:49Pressemelding

During Visioneering 2018, XPRIZE’s annual gathering of philanthropists and innovators to evaluate concepts for future competitions, the Foundation revealed the results of its latest, completed XPRIZE. The Skysource / Skywater Alliance was announced as the grand prize winner of the $1.75M Water Abundance XPRIZE, a two-year competition aimed at alleviating the global water crisis with energy-efficient technologies that harvest fresh water from thin air. In addition at Visioneering, five new prize concepts were evaluated with top honors going to a prize concept called “Coral Survival”, a prize designed to protect and restore coral reefs. This prize will move forward into the XPRIZE pipeline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181022005795/en/ The Skysource / Skywater Alliance team, based in Venice Beach, California, wins the Water Abundance XPRIZE (Photo: Business Wire) The Water Abundance XPRIZE, powered by the Tat

Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 17:15Pressemelding

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin

First Data Polska Deploys Inside Secure’s Mobile Payment Technology To Securely and Easily Connect to Mastercard and Visa22.10.2018 15:36Pressemelding

Regulatory News: Inside Secure (Paris:INSD) (Euronext Paris: INSD), at the heart of security solutions for mobile and connected devices, today announced that First Data Polska S.A., a division of the global leader in commerce-enabling technology, selected Inside Secure technology to enable secure and flexible connections to Mastercard and Visa. First Data Polska S.A. chose Inside Secure’s Mobile Payment Client to easily integrate their solution with the Visa Token Service (VTS) and Mastercard Digital Enablement Service (MDES) – today’s major tokenization services that convert sensitive data into unique tokens that allow mobile payments to be processed. “Security and reliability are continual requirements for our services,” said Jolanta Rycerz, Member of Management Board at First Data Polska S.A. “We see Inside Secure as a valuable technology provider that enables us to easily migrate to the latest mobile payment technology and security standards. Thanks to Inside Secure, our customers,

PMI Launches Search for Next President and CEO22.10.2018 14:00Pressemelding

Project Management Institute (PMI), the world’s leading professional membership organization for project managers, announced today that it has retained Heidrick & Struggles to help the organization find its next President and Chief Executive Officer (CEO). The dynamic leader shall oversee the implementation of a new strategic plan and guide the organization toward a future designed to help thousands of project professionals around the world accelerate their careers and make ideas a reality. Heidrick & Struggles is a premier provider of executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services globally. PMI will conduct a comprehensive global review of both internal and external candidates for this key position. The selected candidate will embody PMI’s core values and possess the skillsets necessary to advance the organization’s key goals. PMI’s next President and CEO will help it execute a bold new multi-year initiative d

E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 13:43Pressemelding

E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t

Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 12:00Pressemelding

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t